A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model

被引:84
作者
Choi, Hyounjeong
Eo, Haekwan
Park, Kyoungcheol
Jin, Mirim
Park, Eun-Jin
Kim, Seon-Hee
Park, Jeong Euy
Kim, Sunyoung [1 ]
机构
[1] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea
[2] Seoul Natl Univ, Helixir Co Ltd, Biotechnol Incubating Ctr, Seoul 151742, South Korea
[3] Sungkyunkwan Univ, Sch Med, Div Cardiol, Samsung Med Ctr, Seoul 135710, South Korea
基金
新加坡国家研究基金会;
关键词
Cucurbita moschata; PG105; obesity; high fat diet-induced obesity mouse model; beta-oxidation; PPAR alpha; lipid metabolism;
D O I
10.1016/j.bbrc.2007.05.107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the screening of a variety of plant sources for their anti-obesity activity, it was found that a water-soluble extract, named PG105, prepared from stem parts of Cucurbita moschata, contains potent anti-obesity activities in a high fat diet-induced obesity mouse model. In this animal model, increases in body weight and fat storage were suppressed by 8-week oral administration of PG105 at 500 mg/kg, while the overall amount of food intake was not affected. Furthermore, PG105 protected the development of fatty liver and increased the hepatic P-oxidation activity. Results from blood analysis showed that the levels of triglyceride and cholesterol were significantly lowered by PG105 administration, and also that the level of leptin was reduced, while that of adiponectin was increased. To understand the underlying mechanism at the molecular level, the effects of PG105 were examined on the expression of the genes involved in lipid metabolism by Northern blot analysis. In the liver of PG105-treated mice, the mRNA level of lipogenic genes such as SREBP-Ic and SCD-1 was decreased, while that of lipolytic genes such as PPAR alpha, ACO-1, CPT-1, and UCP-2 was modestly increased. Our data suggest that PG105 may have great potential as a novel anti-obesity agent in that both inhibition of lipid synthesis and acceleration of fatty acid breakdown are induced by this reagent. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:419 / 425
页数:7
相关论文
共 12 条
[1]   Adipose tissue as an endocrine organ [J].
Ahima, Rexford S. .
OBESITY, 2006, 14 :242-249
[2]   Drug Treatment of Obesity [J].
Bray G.A. .
Reviews in Endocrine and Metabolic Disorders, 2001, 2 (4) :403-418
[3]   Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives [J].
Chapman, MJ .
ATHEROSCLEROSIS, 2003, 171 (01) :1-13
[4]   Obesity: What mental health professionals need to know [J].
Devlin, MJ ;
Yanovski, SZ ;
Wilson, GT .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) :854-866
[5]   Management of obesity as a chronic disease: Nonpharmacologic, pharmacologic, and surgical options [J].
Fujioka, K .
OBESITY RESEARCH, 2002, 10 :116S-123S
[6]   Ruminant adaptation to negative energy balance - Influences on the etiology of ketosis and fatty liver [J].
Herdt, TH .
VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 2000, 16 (02) :215-+
[7]   Increased lipogenic capacity of the islets of obese rats - A role in the pathogenesis of NIDDM [J].
Lee, Y ;
Hirose, H ;
Zhou, YT ;
Esser, V ;
McGarry, JD ;
Unger, RH .
DIABETES, 1997, 46 (03) :408-413
[8]  
Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI [10.1007/s00018-003-3216-3, 10.1155/2010/612089]
[9]   Drug treatments for obesity: orlistat, sibutramine, and rimonabant [J].
Padwal, Raj S. ;
Majumdar, Sumit R. .
LANCET, 2007, 369 (9555) :71-77
[10]   Lipotoxicity: when tissues overeat [J].
Schaffer, JE .
CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (03) :281-287